These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7384189)

  • 1. [On the polymorphism of Barbiturates in powers and tablets. Part 5: The dissolution of recrystallized barbital substances and their release from tablet (author's transl)].
    Hollenbach K; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1980 Feb; 35(2):95-8. PubMed ID: 7384189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [On the Polymorphism of barbiturates in powders and tablets. Part 4: the dissolution of barbital B and barbital A (modifications I and III and their release from tablets (author's transl)].
    Hollenbach K; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1980 Jan; 35(1):32-5. PubMed ID: 7384174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [On the polymorphism of barbiturates in powders and tablets. Part 1: Crystal optical studies on, and melting behaviour of barbital (author's transl)].
    Hollenbach K; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1979; 34(3):164-7. PubMed ID: 450956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [On the polymorphism of barbiturates in powders and tablets - Part 3: The effect of the pressing power on the modification of barbital (author's transl)].
    Pintye-Hódi K; Hollenbach K
    Pharmazie; 1979 Dec; 34(12):807-8. PubMed ID: 545349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the polymorphism of barbital.
    Grabowska I; Kaliszan R
    Pol J Pharmacol Pharm; 1976; 28(5):529-36. PubMed ID: 1012979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the polymorphism of barbiturates in powders and tablets. Part 2: On the infrared spectroscopy and the X-ray diffractometry of barbital (author's transl)].
    Hollenbach K; Mezösi J; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1979 Apr; 34(4):240-2. PubMed ID: 482331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On the polymorphism of barbiturates in powders and tablets. 6: Properties and behaviour of a spray-dried barbital preparation].
    Matzkó-Hollenbach K; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1982 Aug; 37(8):562-5. PubMed ID: 7146063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of physicomechanical properties of carbamazepine by recrystallization at different pH values.
    Javadzadeh Y; Mohammadi A; Khoei NS; Nokhodchi A
    Acta Pharm; 2009 Jun; 59(2):187-97. PubMed ID: 19564143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anomalous dissolution behaviour of tablets prepared from sugar glass-based solid dispersions.
    van Drooge DJ; Hinrichs WL; Frijlink HW
    J Control Release; 2004 Jul; 97(3):441-52. PubMed ID: 15212876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo/in vitro correlations for four differently dissolving ketorolac tablets.
    Gordon MS; Chowhan Z
    Biopharm Drug Dispos; 1996 Aug; 17(6):481-92. PubMed ID: 8866039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bioavailability of diazepam from uncoated tablets in humans--Part I: correlation with the dissolution rates of the tablets.
    Ogata H; Aoyagi N; Kaniwa N; Koibuchi M; Shibazaki T; Ejima A; Tsuji S; Kawazu Y
    Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):159-65. PubMed ID: 7076345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of nitroglycerin tablets submitted by U.S. hospitals.
    Crabbs WC; Dow ML; Juhl YH; Page DP
    Am J Hosp Pharm; 1983 Dec; 40(12):2170-5. PubMed ID: 6419589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The dynamics of the drug release from tablets. Part 7: Comparison of three liberation models on Cholestil tablets (author's transl)].
    Pasich J; Niedworok E; Zajaç M
    Pharmazie; 1980 Dec; 35(12):778. PubMed ID: 7208581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefdinir: A comparative study of anhydrous vs. monohydrate form. Microstructure and tabletting behaviour.
    Cabri W; Ghetti P; Alpegiani M; Pozzi G; Justo-Erbez A; Pérez-Martínez JI; Villalón-Rubio R; Monedero-Perales MC; Muñoz-Ruiz A
    Eur J Pharm Biopharm; 2006 Oct; 64(2):212-21. PubMed ID: 16846727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissolution properties of different designed and formulated salbutamol tablet dosage forms.
    Ozkan Y; Savaşer A; Ozalp Y; Işimer A
    Acta Pol Pharm; 2000; 57(4):271-6. PubMed ID: 11126615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electron-microscopic studies on the texture of sulphathiazole and sulphathiazole tablets (author's transl)].
    Kedvessy G; Selmeczi B; Pintye-Hódi K; Kala H; Moldenhauer H; Giese R
    Pharmazie; 1982 Feb; 37(2):132-4. PubMed ID: 7071119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The dynamics of the drug release from dragées. Part 3: Indometnacin (author's transl)].
    Wojdak H; Pasich J
    Pharmazie; 1980 Aug; 35(8):480-1. PubMed ID: 7433498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Barbital buffer in tablets as a solvent for complement fixation test (CFT)].
    Królak M; Janicki S; Starostka K; Błaszczyk B
    Pol Arch Weter; 1982; 23(2):111-22. PubMed ID: 7167394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
    Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
    Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a dissolution test for a once-a-day combination tablet of immediate-release cetirizine dihydrochloride and extended-release pseudoephedrine hydrochloride.
    Likar MD; Mansour HL; Harwood JW
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):543-51. PubMed ID: 15975755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.